UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Standing on Shoulders: Interferon Research From Viral Interference to Lupus Pathogenesis and Treatment

Arthritis & rheumatology (Hoboken, N.J.), 2024-07, Vol.76 (7), p.1002-1012

2024

Volltextzugriff (PDF)

Hydroxychloroquine and lupus flare: a good drug, but we need to do better

Annals of the rheumatic diseases, 2022-03, Vol.81 (3), p.303-305

2022

Volltextzugriff (PDF)

What Causes Lupus Flares?

Current rheumatology reports, 2016-03, Vol.18 (3), p.14, Article 14

2016

Volltextzugriff (PDF)

Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8

Science translational medicine, 2018-01, Vol.10 (423)

2018

Volltextzugriff (PDF)

Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares

Lupus, 2024-08, Vol.33 (9), p.938-947

2024

Volltextzugriff (PDF)

Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes

Journal of autoimmunity, 2018-03, Vol.88, p.75-82

2018

Volltextzugriff (PDF)

Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment

Frontiers in immunology, 2022-08, Vol.13, p.980079

2022

Volltextzugriff (PDF)

Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations

Rheumatology (Oxford, England), 2023-07, Vol.62 (7), p.2534-2538

2023

Volltextzugriff (PDF)

Low Peripheral B-Cell Counts in Patients With Systemic Rheumatic Diseases Due to Treatment With Belimumab and/or Rituximab Are Associated With Low Antibody Responses to Primary COVID-19 Vaccination

HSS journal, 2023-05, Vol.19 (2), p.180-186

2023

Volltextzugriff (PDF)

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis

Arthritis & rheumatology (Hoboken, N.J.), 2021-01, Vol.73 (1), p.121-131

2021

Volltextzugriff (PDF)

Venous Thromboembolic Events in African American Lupus Patients in Association With Antiphospholipid Antibodies Compared to White Patients

Arthritis care & research (2010), 2022-04, Vol.74 (4), p.656-664

2022

Volltextzugriff (PDF)

Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses

The Journal of experimental medicine, 2022-11, Vol.219 (11)

2022

Volltextzugriff (PDF)

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

Annals of the rheumatic diseases, 2011-06, Vol.70 (6), p.1003-1009

2011

Volltextzugriff (PDF)

Feasibility, Validity, and Reliability of the 10-item Patient Reported Outcomes Measurement Information System Global Health Short Form in Outpatients with Systemic Lupus Erythematosus

Journal of rheumatology, 2018-03, Vol.45 (3), p.397-404

2018

Volltextzugriff (PDF)

Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus

Journal of rheumatology, 2017-07, Vol.44 (7), p.1024-1031

2017

Volltextzugriff (PDF)

Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients

Arthritis & rheumatology (Hoboken, N.J.), 2010-12, Vol.62 (12), p.3607-3614

2010

Volltextzugriff (PDF)

Expression of APOBEC family members as regulators of endogenous retroelements and malignant transformation in systemic autoimmunity

Clinical immunology (Orlando, Fla.), 2021-02, Vol.223, p.108649-108649, Article 108649

2021

Volltextzugriff (PDF)

The Case | Knee pain and allograft dysfunction in a kidney transplant recipient

Kidney international, 2020-02, Vol.97 (2), p.429-430

2020

Volltextzugriff (PDF)

Responsiveness of the Patient‐Reported Outcomes Measurement Information System Global Health Short Form in Outpatients With Systemic Lupus Erythematosus

Arthritis care & research (2010), 2020-09, Vol.72 (9), p.1282-1288

2020

Volltextzugriff (PDF)

A case of inflammatory cerebral amyloid angiopathy after ischemic stroke - a potential risk factor related to blood-brain barrier disruption

Clinical imaging, 2022-02, Vol.82, p.161-165

2022

Volltextzugriff (PDF)

Responsiveness of PROMIS ® Global Health Short Form in Outpatients with Systemic Lupus Erythematosus

Arthritis care & research (2010), 2020-09, Vol.72 (9), p.1282-1288

2020

Volltextzugriff (PDF)

Enhanced Rho‐Associated Protein Kinase Activation in Patients With Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2013-06, Vol.65 (6), p.1592-1602

2013

Volltextzugriff (PDF)

308 Transcriptional profiles associated with pericarditis in patients with systemic lupus erythematosus (SLE) identify purine metabolism pathway genes as candidate mediators

Lupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A23-A23

2024

Volltextzugriff (PDF)

Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2012-12, Vol.64 (12), p.4040-4047

2012

Volltextzugriff (PDF)

Antiinflammatory strategies, not just B cell depletion, are required for optimal therapy for severe proliferative lupus nephritis: Comment on the article by Rovin et al

Arthritis & rheumatology (Hoboken, N.J.), 2012-10, Vol.64 (10), p.3486-3486

2012

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Aktive Filter

ThemaLupus Erythematosus, Systemic - Immunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Englisch
(82)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(45)
Science & Technology
(45)
Rheumatology
(35)
Humans
(34)
Systemic Lupus Erythematosus
(20)
Lupus
(19)
Female
(17)
Biological And Medical Sciences
(13)
Adult
(12)
Male
(11)
Medical Sciences
(10)
Immunology
(9)
Patients
(9)
Aged
(8)
Autoimmune Diseases
(8)
Lupus Erythematosus, Systemic - Blood
(8)
Middle Aged
(8)
Gene Expression
(7)
Diseases Of The Osteoarticular System
(6)
Lupus Erythematosus, Systemic - Diagnosis
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Standing on Shoulders: Interferon Research From Viral Interference to Lupus Pathogenesis and Treatment

Hydroxychloroquine and lupus flare: a good drug, but we need to do better

What Causes Lupus Flares?

Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8

Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares

Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes

Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment

Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations

Low Peripheral B-Cell Counts in Patients With Systemic Rheumatic Diseases Due to Treatment With Belimumab and/or Rituximab Are Associated With Low Antibody Responses to Primary COVID-19 Vaccination

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis

Venous Thromboembolic Events in African American Lupus Patients in Association With Antiphospholipid Antibodies Compared to White Patients

Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

Feasibility, Validity, and Reliability of the 10-item Patient Reported Outcomes Measurement Information System Global Health Short Form in Outpatients with Systemic Lupus Erythematosus

Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus

Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients

Expression of APOBEC family members as regulators of endogenous retroelements and malignant transformation in systemic autoimmunity

The Case | Knee pain and allograft dysfunction in a kidney transplant recipient

Responsiveness of the Patient‐Reported Outcomes Measurement Information System Global Health Short Form in Outpatients With Systemic Lupus Erythematosus

A case of inflammatory cerebral amyloid angiopathy after ischemic stroke - a potential risk factor related to blood-brain barrier disruption

Responsiveness of PROMIS ® Global Health Short Form in Outpatients with Systemic Lupus Erythematosus

Enhanced Rho‐Associated Protein Kinase Activation in Patients With Systemic Lupus Erythematosus

308 Transcriptional profiles associated with pericarditis in patients with systemic lupus erythematosus (SLE) identify purine metabolism pathway genes as candidate mediators

Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus

Antiinflammatory strategies, not just B cell depletion, are required for optimal therapy for severe proliferative lupus nephritis: Comment on the article by Rovin et al

Aktive Filter

Suchergebnisse filtern